Offering You Practical Solutions With Outstanding Results 

NSF International has expanded its range of services, bringing additional pharma and biotech expertise to you directly, when you need it. 

Our new and expanded remote and virtual auditing and consultancy services can provide you with the tools you need to stay agile and proactive during this time. With rapid access to our credible and seasoned experts, we can help you to develop timely responses to the challenges that lay ahead. Contact our team today – we’re here to help.

About NSF: Global Experts for Pharmaceutical Consulting, Auditing and Training 

Our Remote Services 

REMOTE AND VIRTUAL GMP AUDITS

NSF’s four-step process for remote GMP auditing can help you to unlock supply chains and meet cGMP needs. Using our network of international GMP experts, e-rooms and videoconferencing, NSF can offer a hybrid approach to auditing that is both insightful and timely. 

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Find out more about virtual GMP audits >>

Watch the latest webinar 'An Update on Remote and Virtual GMP Audits’ >>

INSTRUCTOR-LED VIRTUAL TRAINING AND eLEARNING

NSF’s virtual training courses are delivered via a combination of live instructor-led virtual classrooms and independent pre- and post-course activities. Our expert coaches will be on hand throughout to guide you through the interactive sessions. 

Upcoming virtual courses >>

NSF’s self-paced eLearning can be completed at a time and place to suit you. They include targeted and highly focused ‘how to’ sessions on common industry themes as well as essential introductions and overviews to those new to the industry.

eLearning courses >>

All training can be tailored to suit your organizational needs, do not hesitate to get in touch to discuss your requirements.

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

REMOTE GxP CONSULTANCY

NSF’s remote consultancy service can provide you with quick, accurate and practical guidance on the challenges that lay ahead. Our four expanding services include: 

  • Live consultancy
  • 1-1 management & technical coaching 
  • Remote review and authorship of local policies and procedures
  • Remote support to your pharma quality system

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Find our more about NSF’s remote GxP consultancy 

New NSF Journal: Time to Rethink

Featured articles:

  • Rethinking leadership, supply chains, vaccine development, and managing business in an uncertain world
  • Streamlining operations in a COVID-19 environment
  • Meeting FDA submission requirements when developing and implementing changes to risk evaluation and mitigation strategies (REMS)
  • A detailed regulatory update section, including a review of the U.S. regulatory preparedness in facing the COVID-19 pandemic.

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

Remediation Case Study

GMP remediation projects are rarely just about upgrading SOPs and retraining staff. John Johnson shares how the best firms use remediation projects proactively to alter the mind-set for quality and reduce ongoing costs to the business.

Watch the Video >>

View NSF’s latest Journal >>

Get In Touch

Have a question or want more information about our services? 

Contact our team at pharmamail@nsf.org or visit www.nsfpharma.org.

SIGN UP FOR YOUR COMPLIMENTARY JOURNAL AND MONTHLY E-JOURNAL

REMOTE AND VIRTUAL GMP AUDITS

NSF’s four-step process for remote GMP auditing can help you to unlock supply chains and meet cGMP needs. Using our network of international GMP experts, e-rooms and videoconferencing, NSF can offer a hybrid approach to auditing that is both insightful and timely.

Find out more about virtual GMP audits >>

Watch the latest webinar 'An Update on Remote and Virtual GMP Audits’ >>

INSTRUCTOR-LED VIRTUAL TRAINING AND eLEARNING

NSF’s virtual training courses are delivered via a combination of live instructor-led virtual classrooms and independent pre- and post-course activities. Our expert coaches will be on hand throughout to guide you through the interactive sessions. 

Upcoming virtual courses >>

NSF’s self-paced eLearning can be completed at a time and place to suit you. They include targeted and highly focused ‘how to’ sessions on common industry themes as well as essential introductions and overviews to those new to the industry. 

eLearning courses >>

All training can be tailored to suit your organizational needs, do not hesitate to get in touch to discuss your requirements.

REMOTE GxP CONSULTANCY

NSF’s remote consultancy service can provide you with quick, accurate and practical guidance on the challenges that lay ahead. Our four expanding services include: 

  • Live consultancy
  • 1-1 management & technical coaching 
  • Remote review and authorship of local policies and procedures
  • Remote support to your pharma quality system

Find our more about NSF’s remote GxP consultancy >>

NEW NSF JOURNAL: TIME TO RETHINK

Featured articles:

  • Rethinking leadership, supply chains, vaccine development, and managing business in an uncertain world
  • Streamlining operations in a COVID-19 environment
  • Meeting FDA submission requirements when developing and implementing changes to risk evaluation and mitigation strategies (REMS)
  • A detailed regulatory update section, including a review of the U.S. regulatory preparedness in facing the COVID-19 pandemic.

View NSF’s latest Journal >>

Go to article: Home | Pause for thoughtGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: NewsGo to article: BaxterGo to article: Covid-19 executive briefing by GlobalDataGo to article: ELPRO Monitoring SolutionsGo to article: Abivax’s ABX464 enticing in theory for Covid-19 but mechanism, trial design issues belie potential for successGo to article: Abiomed’s Impella receives FDA Emergency Use Authorization during Covid-19Go to article: FargoGo to article: Disruptions to global oncology trials have fallen to a three-month lowGo to article: MimotopesGo to article: AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine cliGo to article: Biotech IPO valuation relies on data to enter capital markets during Covid-19 paGo to article: Nelson LabsGo to article: The pharma industry briefingGo to article: Pfeiffer VacuumGo to article: A century of cultures: celebrating the world’s oldest lab culture collectionGo to article: SkyepharmaGo to article: Gut feeling: exploring the therapeutic potential of the gut-brain axisGo to article: OptelGo to article: Crabby concoctions: why pharma’s thirst for crustacean blood is up for debateGo to article: Air FranceGo to article: Debunking myths about puberty blockers for transgender childrenGo to article: MicronovaGo to article: Hiring from home: pharma recruitment in the age of Covid-19 Go to article: Nipro PharmapackagingGo to article: Q&A: breaking new ground in pharma packaging with HoneywellGo to article: WipotecGo to article: Treatment-resistant rare diseases: exploring landmark drug approvals in 2020Go to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Modernising pharma patents: can AI be an inventor?Go to article: ILC Dover Go to article: Boosting agility to accelerate project timescales Go to article: Scandinavian HealthGo to article: Doing the right thing: the enhanced case for complianceGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue